The Beijing-based American Chamber of Commerce said on Friday that companies in the pharmaceutical sector had reported that ...

Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...

Takeda Pharmaceuticals, Japan's largest drugmaker, has undergone a sweeping transformation under CEO Christophe Weber, ...

The Basel-based company said the investment would go toward high-tech research and development sites and new manufacturing ...

Pharmaceutical companies in China are reporting that they have been able to import some drugs over the past week with tariff ...

U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...

Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...

The Trump administration is proceeding with probes into the national security implications of pharmaceutical imports.

Exiger warns the U.S. is overly reliant on foreign countries to make key components of crucial medications as the Trump ...

A unique Novo Nordisk legal challenge to the Medicare drug pricing program could have big implications for the pharma ...

In addition to pharmaceuticals, Trump has also called for Section 232 investigations of semiconductors and critical minerals.

Dr. Soliman Abdel Kader Fakeeh Hospital Co. (Fakeeh Care) and its subsidiaries, Fakeeh Care Group and Fakeeh Care, signed a ...